女性在接受分支/开窗腔内主动脉瘤修复术后早期发病率和死亡率升高,但中期生存率与男性相似
单中心2007至2020年242例分支/开窗腔内主动脉修复患者中,女性57例(23.5%),中位随访3.3年。女性术中时间、并发症及住院死亡率更高,但6年生存率两性相似(风险比0.95,P=0.83)。
要点
- 女性住院死亡率12.3% vs 男性2.7%(P=0.004),但6年生存率相似(风险比0.95,P=0.83)。
- 女性术中并发症更多(61.4% vs 35.7%,P<0.001),手术时间和透视时间更长。
- 女性脊髓缺血(15.8% vs 3.8%)和肠缺血(10.5% vs 2.7%)发生率更高。
核心结论
- 女性接受分支/开窗腔内主动脉修复术的术中时间、并发症及住院发病率和死亡率显著高于男性,但中期结局相似。
- 解剖和动脉粥样硬化差异可能导致了观察到的住院期间差异。
研究设计与样本
- 单中心2007年至2020年对242例接受分支和/或开窗腔内主动脉修复术的患者进行病历回顾,其中女性57例(23.5%)。
- 中位随访时间为3.3年(四分位距1.6-5.3年),主要终点为中期(6年)生存率。
主要发现
- 女性与男性在就诊时年龄(75.9±5.4岁 vs 74.7±7.2岁,P=0.162)和动脉瘤大小(64.9±6.8 mm vs 65.8±9.4 mm,P=0.41)无统计学显著差异。
- 女性肾下腹主动脉瘤比例更低(45.6% vs 73%,P<0.001),接受更多Crawford II型胸腹主动脉瘤覆盖(26.3% vs 10.8%,P=0.004),中/重度靶血管狭窄发生率更高(29.8% vs 14%,P=0.022)。
- 女性术中手术时间更长(530分钟[IQR 425-625] vs 420分钟[IQR 350-510],P<0.001),透视时间更长(124.1±49分钟 vs 107.3±43.5分钟,P=0.017),造影剂用量更多(200 mL[IQR 150-270] vs 175 mL[IQR 130-225],P=0.005)。
- 女性非计划术中操作(45.6% vs 28.1%,P=0.043)、移植物输送问题(24.6% vs 4.9%,P<0.001)及额外术中并发症(61.4% vs 35.7%,P<0.001)均增加。
- 女性术后ICU住院时间更长(3天[IQR 1-5] vs 1天[IQR 1-3],P=0.002),总住院时间更长(8天[IQR 5-13] vs 5天[IQR 3-9],P<0.001),脊髓缺血(15.8% vs 3.8%,P=0.001)和肠缺血(10.5% vs 2.7%,P=0.013)发生率更高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to identify sex-related differences in outcomes following branched and/or fenestrated endovascular aortic repair (B/FEVAR) for thoracoabdominal (TAAA) and juxtarenal (JRAA) aortic aneurysms. METHODS: Chart review completed on 242 B/FEVAR patients (57 female; 23.5%) between 2007 and 2020 at a single center. Median follow-up time was 3.3 years (interquartile range [IQR], 1.6-5.3 years). RESULTS: No statistically significant differences in age (females, 75.9 ± 5.4 years vs males, 74.7 ± 7.2 years; P = .162) or aneurysm size (64.9 ± 6.8 vs 65.8 ± 9.4 mm; P = .41) at presentation were observed between sexes. Females presented with fewer JRAAs (45.6% vs 73%; P < .001) and received more Crawford extent II (26.3% vs 10.8%; P =.004) TAAA coverage. Increased incidence of moderate/severe target vessel stenosis (29.8% vs 14%; P = .022) was observed in female patients. Intraoperatively, females had higher procedure times (530 [IQR, 425-625] vs 420 [IQR, 350-510] minutes; P < .001), fluoroscopy times (124.1 ± 49 vs 107.3 ± 43.5 minutes; P = .017), and contrast usage (200 [IQR, 150-270] vs 175 [IQR, 130-225] mL; P = .005). Unplanned intraoperative maneuvers (45.6% vs 28.1%; P = .043), graft delivery issues (24.6% vs 4.9%; P < .001), and additional intraoperative complications (61.4% vs 35.7%; P < .001) were also increased in females. Postoperatively, females had a longer intensive care unit (3 [IQR, 1-5] vs 1 [IQR, 1-3] days; P = .002) and hospital stay (8 [IQR, 5-13] vs 5 [IQR, 3-9] days; P < .001) and experienced increased rates of spinal cord ischemia (15.8% vs 3.8%; P = .001) and bowel ischemia (10.5% vs 2.7%; P = .013). In-hospital mortality (12.3% vs 2.7%; P = .004) was higher in female patients but midterm (6-year) survival was 60.2% for all patients (95% confidence interval, 53.0%-68.5%) and was similar between sexes (hazard ratio, 0.95; P = .83), which were the primary endpoints. No sex differences in midterm follow-up reintervention, endoleak, and rupture rates were observed. CONCLUSIONS: Females experienced significantly higher B/FEVAR intraoperative times, complications, and in-hospital morbidity and mortality compared with males but similar midterm outcomes. Anatomic and atherosclerotic differences may have contributed to the observed in-hospital differences.
引用
- Forbes SM, Mahmood DN, Rocha R, et al. Females experience elevated early morbidity and mortality but similar midterm survival compared to males after branched/fenestrated endovascular aortic aneurysm repair. J Vasc Surg. 2022. PMID: 36581014. doi:10.1016/j.jvs.2022.12.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。